Influx HealthtechNSE:INFLUX -0.65%32 Pretax Margin % is 17.68% as of Mar. 2026, which is 17% above its 10-year median of 15.06. GuruFocus rates NSE:INFLUX with a GF Score™ of 32/100. The stock has 4 warning signs investors should review. Among 961 Drug Manufacturers companies, Influx Healthtech ranks better than 78.67% on this metric.
The historical rank and industry rank for Influx Healthtech's Pretax Margin % or its related term are showing as below:
NSE:INFLUX'
s Pretax Margin % Range Over the Past 10 Years
Min: 10.19 Med: 15.06 Max: 18.55
Current: 18.55
NSE:INFLUX's Pretax Margin % is ranked better than 78.67% of 961
companies
in the Drug Manufacturers industry
Industry Median: 7.28
vs NSE:INFLUX: 18.55
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Influx Healthtech Pretax Margin % Related Terms
Influx Healthtech Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Influx Healthtech's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:INFLUX vs ZTS, UTHR: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Influx Healthtech's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Influx Healthtech Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Influx Healthtech's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Influx Healthtech's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Influx Healthtech (NSE:INFLUX) has a Pretax Margin % of 17.68% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Influx Healthtech and its competitors. This is 17% above median its historical median of 15.06. Over the past decade, Influx Healthtech's Pretax Margin % has ranged from 10.19 to 18.55. According to the industry distribution chart, Influx Healthtech ranks #205 out of 961 companies in the Drug Manufacturers industry, placing it in the top 21.3%.
Is Influx Healthtech's Pretax Margin % too high?
Influx Healthtech's current Pretax Margin % of 17.68% is 17% above median its 10-year median of 15.06. Over the past 10 years, this metric has ranged from a low of 10.19 to a high of 18.55. The Drug Manufacturers industry median Pretax Margin % is 7.28. Influx Healthtech's value of 17.68% is 142.9% above this industry median. Based on the distribution chart, Influx Healthtech ranks #205 out of 961 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Influx Healthtech has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Influx Healthtech's Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Influx Healthtech ranks #205 out of 961 companies for Pretax Margin %. This places Influx Healthtech in the top 21% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 7.28. Influx Healthtech's value of 17.68% is 142.9% above this benchmark. Historically, Influx Healthtech's own Pretax Margin % has ranged from 10.19 to 18.55 over the past decade. While the company's 10-year median is 15.06 vs. the industry median of 7.28, Influx Healthtech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.28, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Influx Healthtech's current Pretax Margin % of 17.68% is 142.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Influx Healthtech and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Influx Healthtech's current Pretax Margin % is 17.68%, which is 17% above median its own 10-year median of 15.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Influx Healthtech stock overvalued right now?
Influx Healthtech (NSE:INFLUX) has a current Pretax Margin % of 17.68%. The current Pretax Margin % is 17.68%, which is 17% above median its 10-year median of 15.06 and 142.9% above the Drug Manufacturers industry median of 7.28. Influx Healthtech's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Influx Healthtech (NSE:INFLUX), the current Pretax Margin % is 17.68% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Influx Healthtech Ltd is a Mumbai-based, healthcare-focused company specialising in contract manufacturing. The company operates manufacturing facilities located in Thane. Its expertise spans the production of Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, Homecare Products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including tablets, capsules, and injectables. The company generates the majority of its revenue from sale of products.
32GF Score
Get the complete analysis for NSE:INFLUX
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INFLUX has been successfully added to your 